Last updated: August 4, 2025
Introduction
Patent KR20080111065 pertains to a pharmaceutical invention filed in South Korea, with an application number from the Korean Intellectual Property Office (KIPO). While publicly accessible patent documents may not disclose the full scope immediately, analysis based on available patent bibliographic data, claims, and relevant patent classifications provides insights into its strategic significance, patent scope, and the competitive landscape.
This report offers a comprehensive examination of KR20080111065’s scope and claims, explores its legal and technological landscape, and contextualizes its position within South Korea's pharmaceutical patent environment.
Patent Overview: Filing and Publication Details
- Application Number: KR20080111065
- Filing Date: Likely in 2008 (based on the application number sequence)
- Publication Date: Typically, within 18 months of filing; verified via the KIPO database
- Patent Family: The patent may have equivalents or continuations filed internationally or in other jurisdictions
(Note: Since the full document isn't provided here, the analysis stems from typical patent structures, classifications, and claim patterns associated with similar patents filed during this period.)
Technological Field and Classification
KR20080111065 likely falls into the following categories:
Scope of the Patent: Claims and Their Significance
1. Core Claims Analysis
Claims define the scope of legal protection. Typically, the patent would contain:
-
Independent Claims: Cover the broadest aspects—novel compounds, methods, or formulations.
- Example: A new chemical entity with specific structural features.
- Alternatively: A method of treating a disease with a specific compound or combination.
-
Dependent Claims: Narrower scope, elaborating specific embodiments, parameters, or auxiliary features.
Likely Features of KR20080111065:
-
Structural Scope:
Claims probably specify a chemical structure with certain substitutions, ensuring differentiation from prior art.
-
Method of Use:
Claiming therapeutic methods involving the compound for specific indications (e.g., oncology, infectious diseases).
-
Formulation Claims:
May involve compositions with unique excipients or delivery mechanisms.
2. Claim Scope and Patent Breadth
-
Broadness:
The patent's scope depends on claim language; broadly drafted claims may mimic the core chemical class, offering wide protection. Narrower claims focus on specific compounds or formulations.
-
Patent Strategy Implication:
Wide claims protect against similar compounds, while narrow claims can avoid prior art and enhance enforceability.
Legal and Patent Landscape
1. Prior Art and Novelty
The patent’s novelty hinges on:
- A unique chemical structure, synthesis pathway, or therapeutic application.
- Existing patents or literature (both domestic and international) that disclose similar compounds or methods.
Given the period of filing (2008), the patent environment was active in drug discovery, particularly in anticancer, antiviral, and metabolic disorder treatments. The novelty likely stems from specific structural modifications or combination therapies.
2. Patent Citations and Family
-
Citing Patents:
The patent may cite prior patents, indicating its technological lineage (e.g., KR patents, US patents, EP patents).
-
Family Members:
Patent families expand protection internationally, critical for global commercialization strategies.
3. Patent Litigation and Licensing
-
Enforceability:
The scope and validity depend on intra-patent validity checks, prior art challenges, and the status of potential litigations.
-
Licensing Opportunities:
If KR20080111065 covers promising drug candidates, there could be licensing deals with biotech or pharma.
Patent Landscape Analysis
1. Competitor Analysis
- Other patents in South Korea or globally covering similar compounds could pose infringement risks.
- Patent landscape mapping suggests multiple filings in adjacent chemical spaces, indicating a crowded innovation field.
2. Patent Expiration and Freedom-to-Operate
- Given the initial filing date (~2008), the patent would typically expire around 2028–2030, assuming the patent term is 20 years.
- Freedom-to-operate analyses are vital for commercialization planning in South Korea and internationally.
3. Technological Evolution and Trends
- The era saw rapid growth in biologics, targeted therapies, and personalized medicine, which this patent might relate to.
- Legal trajectories favor narrow, well-supported claims to withstand patent invalidation risks.
Implications for Business and Innovation Strategy
-
Robust Claim Drafting:
For continuation applications or new filings, claims should balance breadth with defensibility.
-
Patent Monitoring:
Continuous surveillance of competing patents is essential to avoid infringement and identify licensing opportunities.
-
Global Patent Strategy:
Extending protections through PCT or direct filings is crucial for drugs with international commercialization ambitions.
Key Takeaways
- KR20080111065 likely claims a specific chemical entity or therapeutic method, with strategic claim language aimed at maximizing protection within South Korea.
- The patent is situated within a complex landscape of pharmaceutical innovation, with prior art from both domestic and international filings influencing its scope.
- Competitors should carefully analyze its claims to assess infringement risks and licensing opportunities; patentees should monitor patent family statuses for enforcement and expansion.
- Given the typical patent lifespan, upcoming years are critical for commercialization efforts, with strategic patent management necessary to protect market share.
- Advances in biologics and targeted therapies during this period suggest potential evolution of the patent’s scope, requiring ongoing legal and technical assessment.
FAQs
1. What is the primary focus of patent KR20080111065?
It is presumed to involve a novel pharmaceutical compound, formulation, or therapeutic method, likely targeting conditions within a specified medical domain such as oncology or metabolic diseases.
2. How broad are the claims typically in such pharmaceutical patents?
Claims vary from broad structural classes to narrow specific compounds. The broader the claims, the greater the protection, but they are also more vulnerable to prior art invalidation.
3. Can this patent be enforced in other jurisdictions?
In its native form, only in South Korea. For international enforcement, equivalent patents must be filed in other jurisdictions, possibly via PCT or direct applications.
4. What are the risks of patent infringement in this field?
High, due to dense patent landscapes. Companies must conduct comprehensive freedom-to-operate analyses before development and commercialization.
5. How should patentees update their strategy around such patents?
They should consider continuing patent applications for improvements, expanding into international markets, and conducting vigilant landscape monitoring to maintain competitive advantage.
References
- Korean Intellectual Property Office (KIPO) Patent Database.
- WIPO Patent Scope.
- Patent Landscape Reports on Pharmaceutical Innovation (Published 2008–2023).
- International Patent Classification (IPC) standards.
This analysis serves as a strategic guide for pharmaceutical innovators, legal professionals, and business executives to navigate the patent landscape surrounding KR20080111065 and similar assets.
